OCULAR THERAPEUTIX, INC cotiza a 7.33 USD y tiene una capitalización bursátil de $1.6B. En los últimos 12 meses ha facturado $52M con un margen de flujo de caja libre del -417.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat …
| Métrica | OCUL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 87.3% | 57.0% | +30.3% |
| Operating Margin | -519.8% | -38.6% | -481.1% |
| Net Margin | -511.9% | -33.6% | -478.3% |
| FCF Margin | -417.5% | -13.9% | -403.6% |
| ROE | -40.6% | -40.4% | -0.2% |
| ROA | -32.9% | -32.0% | -0.9% |
| Current Ratio | 15.39 | 2.84 | +12.55 |
| Debt / Equity | 0.11 | 0.28 | -0.17 |